Skip to main content
logo
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.780
-0.210 (-4.21%)
At close: Sep 11, 2026, 4:00 PM EDT
4.740
-0.040 (-0.83%)
After-hours: Sep 11, 2026, 7:39 PM EDT

Aquestive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
60078832513549156
Market Cap Growth
23.27%142.81%140.67%176.07%-68.73%-13.14%
Enterprise Value
56070028415585169
Last Close Price
4.786.463.562.020.903.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.0917.695.642.671.023.07
PB Ratio
--23.41-5.40-1.27-0.41-1.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
10.3615.734.933.061.793.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.04-1.26-0.63-0.31-0.48-0.69
Net Debt / Equity Ratio
0.702.340.56-0.09-0.25-0.35
Net Debt / EBITDA Ratio
0.761.121.12-0.69-0.76-0.90
Net Debt / FCF Ratio
0.861.490.93-1.28-2.79-0.84
Asset Turnover
0.480.340.730.880.800.81
Inventory Turnover
2.303.042.793.323.954.61
Quick Ratio
6.542.924.181.770.811.83
Current Ratio
7.193.144.682.241.012.15
Return on Assets (ROA)
-29.20%-33.92%-24.21%-16.49%-44.16%-34.71%
Return on Capital Employed (ROCE)
-45.60%-63.00%-37.30%-38.60%-239.80%-86.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.04%-10.63%-13.60%-5.83%-111.37%-45.15%
FCF Yield
-7.66%-6.72%-11.07%-5.47%-22.20%-21.69%
Buyback Yield / Dilution
-27.37%-23.29%-41.58%-25.69%-27.99%-13.15%
SEC Filings: 10-K · 10-Q